Sponsors (2)
The bill prevents future asbestos harms by banning new commercial asbestos products—improving public health and lowering long‑term remediation costs—while leaving existing asbestos in place and imposing transitional costs, limited regulatory flexibility, and some classified exemptions that may delay local transparency.
Construction workers and local communities: the bill bans the manufacture, processing, and distribution of new commercial asbestos products on enactment, sharply reducing future occupational and community asbestos exposure and long‑term disease risk.
State and local governments and hospitals: fewer future remediation and healthcare burdens from newly introduced asbestos sources, potentially reducing long‑term public and health system costs.
Operators of existing chlor‑alkali facilities: a time-limited compliance exception allows continued use of asbestos diaphragms until Jan 1, 2030, giving facilities time to transition to alternatives and avoid immediate disruption.
Homeowners, local governments, and renovation/demolition workers: pre‑enactment installed asbestos is excluded from the ban, leaving existing buildings as ongoing sources of exposure and imposing continued abatement costs and health risks.
Owners and operators of chlor‑alkali facilities and their customers: mandatory replacement of asbestos diaphragms by Jan 1, 2030 will create compliance costs that could raise production costs and, ultimately, consumer prices.
Local communities and workers near sites covered by classified exemptions: allowing withholding of public disclosure for national‑security exemptions could delay community awareness and complicate timely protections for workers and residents.
Based on analysis of 2 sections of legislative text.
Immediately bans manufacture, processing, use, and distribution of commercial asbestos and related articles/mixtures, with limited temporary exceptions for existing chlor‑alkali facilities and a narrow national‑security exemption.
Introduced September 16, 2025 by Suzanne Bonamici · Last progress September 16, 2025
Bans the manufacture, processing, use, and distribution of "commercial asbestos" and mixtures or articles containing it immediately upon enactment, while defining key terms and limiting what counts as distribution. It creates two narrow, time‑bound exceptions: existing chlor‑alkali facilities in operation at enactment may continue to hold and use commercial asbestos diaphragms for production until January 1, 2030; and the President may grant a single national‑security exemption for up to three years (with one possible three‑year extension) under conditions that minimize exposure and include public notice requirements. The Environmental Protection Agency (EPA) Administrator is barred from using a general TSCA waiver for commercial asbestos.